ESPAC-4 long-term follow-up: shall we choose gemcitabine and capecitabine as adjuvant therapy for elderly and low-risk pancreatic adenocarcinoma following surgical resection? - Bertolo, Aaron; Hodul, Pamela; Kim, Dae Won (Annals of Pancreatic Cancer, 2026)